We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Saudi FDA Releases Guidance on Registering Clinical Trials
Saudi FDA Releases Guidance on Registering Clinical Trials
All sponsors planning to conduct clinical trials in Saudi Arabia for the first time must register their studies through the Saudi Clinical Trials Registry, under new guidance issued Aug. 30.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor